Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Experience with extended-infusion meropenem in the management of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii.

× No keyword cloud information.

11 in total

1. Novel treatment approach to combat an infection with Acinetobacter.

Authors: Jeffrey S Stroup; Kendal Mitchell; David Hitzeman
Journal: Proc (Bayl Univ Med Cent) Date: 2010-01

2. Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: a pharmacokinetics/pharmacodynamics-based approach.

Authors: Federico Pea; Pierluigi Viale; Piergiorgio Cojutti; Mario Furlanut
Journal: Antimicrob Agents Chemother Date: 2012-10-08 Impact factor: 5.191

Review 3. Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory.

Authors: Mordechai Grupper; Joseph L Kuti; David P Nicolau
Journal: Clin Microbiol Rev Date: 2016-10 Impact factor: 26.132

4. Stability of Meropenem After Reconstitution for Administration by Prolonged Infusion.

Authors: Sarah Fawaz; Stephen Barton; Laura Whitney; Julian Swinden; Shereen Nabhani-Gebara
Journal: Hosp Pharm Date: 2018-05-30

5. Prolonged versus Intermittent Infusion of β-Lactams for the Treatment of Nosocomial Pneumonia: A Meta-Analysis.

Authors: Ashima Lal; Philippe Jaoude; Ali A El-Solh
Journal: Infect Chemother Date: 2016-06-30

Review 6. Clinical outcomes of prolonged infusion (extended infusion or continuous infusion) versus intermittent bolus of meropenem in severe infection: A meta-analysis.

Authors: Zhenwei Yu; Xiaoping Pang; Xuqi Wu; Chunlei Shan; Saiping Jiang
Journal: PLoS One Date: 2018-07-30 Impact factor: 3.240

7. Randomized Trial of Ceftazidime-Avibactam vs Meropenem for Treatment of Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (REPROVE): Analyses per US FDA-Specified End Points.

Authors: Antoni Torres; Doug Rank; David Melnick; Ludmyla Rekeda; Xiang Chen; Todd Riccobene; Ian A Critchley; Hassan D Lakkis; Dianna Taylor; Angela K Talley
Journal: Open Forum Infect Dis Date: 2019-04-25 Impact factor: 3.835

8. Clinical pharmacokinetics of 3-h extended infusion of meropenem in adult patients with severe sepsis and septic shock: implications for empirical therapy against Gram-negative bacteria.

Authors: Amol T Kothekar; Jigeeshu Vasishtha Divatia; Sheila Nainan Myatra; Anand Patil; Manjunath Nookala Krishnamurthy; Harish Mallapura Maheshwarappa; Suhail Sarwar Siddiqui; Murari Gurjar; Sanjay Biswas; Vikram Gota
Journal: Ann Intensive Care Date: 2020-01-10 Impact factor: 6.925

Review 9. Optimal dosing of antibiotics in critically ill patients by using continuous/extended infusions: a systematic review and meta-analysis.

Authors: Clarence Chant; Ann Leung; Jan O Friedrich
Journal: Crit Care Date: 2013-11-29 Impact factor: 9.097

10. An Evidence-Based Multidisciplinary Approach Focused on Creating Algorithms for Targeted Therapy of Infection-Related Ventilator-Associated Complications (IVACs) Caused by Pseudomonas aeruginosa and Acinetobacter baumannii in Critically Ill Adult Patients.

Authors: Milo Gatti; Bruno Viaggi; Gian Maria Rossolini; Federico Pea; Pierluigi Viale
Journal: Antibiotics (Basel) Date: 2021-12-28